The primary aim is to study change of critical frailty scale (CFS) and health related quality of life (EQ-5D-5L) in a long-term follow-up of ICU survivors. We aim to identify important ICU related predictors for change in CFS and EQ-5D-5L in long term follow up (1 yr). Secondary aim is to investigate how CFS pre-admission is related to intrahospital treatment intensity level, severity score and mortality.
This is a multi-centre norwegian observational, prospective multicenter Norway coordinated from University hospital North Norway, Tromso. The study is approved by The Regional Committee for Medical Research Ethics Northern Norway. The following scores will be assessed by asking the patient and relative during ICU stay: CFS, EQ5DL before current critical illness. The following demographic and clinical data will be retrieved from the medical records: Comorbidity before critical illness, reasons for ICU admission, daily severity score (SOFA- score), length of mechanical ventilation, dialysis, tracheostomy, Habitat before and after ICU treatment, ICU and hospital length of stay, complications retrieved during intensive care treatment, mortality, limitation of treatment. The patients will be followed up with telephone interview after hospital discharge for evaluation of: Comorbidity, CFS, EQ5DData for all sites are collected and managed using RedCap electronic data capture tools. Three research nurses will do the follow up with telephone interviews on all sites and record the data in RedCap. We aim to enroll 300 patients before 31. Des 2024.
Study Type
OBSERVATIONAL
Enrollment
300
Akershus University hospital, General Intensive care department
Lørenskog, Nordbyhagen, Norway
RECRUITINGHaukeland University hospital, General Intensive care unit
Bergen, Norway
RECRUITINGNordlandssykehuset Bodø, Intensivavdelingen
Bodø, Norway
Change in Clinical frailty score
Score from 1 to 9.
Time frame: Change in Clinical Frailty score from 3 months to 12 months follow up
EuroQol 5-Dimension 5-Level (EQ-5D-5L)
The scale measures quality of life on a 5-component scale
Time frame: Change in EQ-5D-5L from 3 months to 12 months
Mortality
Mortality during ICU-stay or subsequent 12 months.
Time frame: ICU-stay or subsequent 12 months.
ICU readmission
ICU readmission rate
Time frame: Long-term follow up (1 yr)
ICU-LOS
ICU length of stay
Time frame: Through total ICU stay, up to 3 months
Treatment intensity level
ICU treatment intensity level
Time frame: From inclusion in the study to discharge from intensive care unit, up to three months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University Hospital of North Norway
Tromsø, Norway
RECRUITINGTrondheim University hospital, General Intensive care department
Trondheim, Norway
RECRUITING